Foghorn Therapeutics Inc. (FHTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...
In a report released yesterday, Jonathan Koh from UOB Kay Hian maintained a Buy rating on Digital Core REIT (DCRU – Research Report), with a ...
AppLovin, Silvercorp Metals and Powell Industries have been selected as the top picks with a high net income ratio.
Vanguard International High Dividend Yield Index Fund offers global diversification and strong dividend income potential.
ProAssurance faces challenges in medical malpractice insurance, but shows improvement in net income. See why I rate PRA stock ...
Growth stocks are equity shares likely to outperform their peers and the broader market. Here's a list of stocks that contain investment potential to beef up your portfolio.
Needham analyst Ami Fadia maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of $133.00.Don't ...
NetEase (NTES) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
Owning mutual funds is a simple long-term investment strategy for growth and income. Here are five funds worth considering ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback